Growth hormone-induced alterations in the insulin-signaling system

Experimental Biology and Medicine

Volumn 227, Issue 3, 2002, Pages 149-157

  Dominici, Fernando P ^a   Turyn, Daniel ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Aging; Diabetes; Growth hormone; Insulin receptor substrate; Insulin signaling

Indexed keywords

CELL SURFACE RECEPTOR; GROWTH HORMONE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN SHC; PROTEIN SOCS 6; PROTEIN TYROSINE KINASE; SUPPRESSOR OF CYTOKINE SIGNALING 1; UNCLASSIFIED DRUG;

AGING; DIABETES MELLITUS; ENZYME ACTIVATION; GLUCOSE METABOLISM; GROWTH HORMONE DEFICIENCY; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; LONG TERM EXPOSURE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR INTRINSIC ACTIVITY; RODENT; SHORT SURVEY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

RODENTIA;

EID: 0036521760     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020222700301     Document Type: Short Survey

References (111)

1. Sonksen PH. Growth hormone replacement in adults with GH deficiency: the first 10 years. Growth Horm IGF Res 8:275-276, 1998.
2. Murray RD, Shalet SM. Growth hormone: current and future therapeutic applications. Expert Opin Pharmacother 1:975-990, 2000.
3. White MF, Kahn CR. The insulin signalling system. J Biol Chem 269:1-4, 1994.
4. White MF. The insulin signalling system and the IRS proteins. Diabetologia 40:S2-S17, 1997.
5. Accili D, Drago J, Lee EJ, Johnson MD, Cool MH, Salvatore P, Asico LD, Jose PA, Taylor SI, Westphal H. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Genet 12:106-109, 1996.
6. Sun XJ, Rothemberg P, Kahn CR, Backer JM, Araki E, Wilden P, Cahill DA, Goldstein BJ, White MF. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352:73-77, 1991.
7. Patti ME, Sun XJ, Bruening JC, Araki E, Lipes MA, White MF, Kahn CR. 4PS/IRS-2 is the alternative substrate of insulin receptor in IRS-1 deficient mice. J Biol Chem 270:24670-24673, 1995.
8. Withers DJ, White M. Perspective: the insulin signaling system: a common link in the pathogenesis of type 2 diabetes. Endocrinology 141:1917-1921, 2000.
9. Shepherd PR, DJ Withers, K Siddle. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J 333:471-490, 1998.
10. Coffer PJ, Jin J, Woodget JR. Protein kinase B(c-Akt): a multifunctional mediator of PI 3-kinase activation. Biochem J 335:1-13, 1998.
11. Sasaoka T, B Draznin, JW Leitner, WJ Langlois, JM Olefsky. Shc is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide releasing factor and p21 ras-GTP formation. J Biol Chem 269:10734-10738, 1994.
12. Yamauchi K, Pessin JE. Insulin receptor substrate-1 (IRS-1) and Shc compete for a limited pool of Grb-2 in mediating insulin downstream signalling. J Biol Chem 269:31107-31114. 1994.
13. Davidson MB. Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev 8:115-131, 1987.
14. Moller N, Jorgensen JO, Abilgard N, Orskov L, Schmitz O, Christiansen JS. Effect of growth hormone on glucose metabolism. Horm Res 36:32-35, 1991.
15. Houssay BA, Anderson E. Diabetogenic action of purified anterior pituitary hormones. Endocrinology 45:627-629, 1949.
16. Cotes PM, Reid E, Young FG. Diabetogenic action of pure anterior pituitary growth hormone. Nature 164:209-211, 1949.
17. Campbell J, Davidson IWF, Lei HP. Production of permanent diabetes by highly purified growth hormone. Endocrinology 46:588-590, 1950.
18. Trimble ER, Atkinson AB, Buchanan KD, Hadden DR. Plasma glucagon and insulin concentrations in acromegaly. J Clin Endocrinol Metab 51:626-631, 1980.
19. Hansen I, Tsalikian E, Beaufrere B, Gerich J, Haymond M, Rizza R. Insulin resistance in acromegaly: defects in both hepatic and extrahepatic insulin action. Am J Physiol 250:E269-E273, 1986.
20. Ezzat S, Forster MJ, Berchtold P, Redelmeier DA, Boerlin V, Harris AG. Acromegaly. Clinical and biochemical features in 500 patients. Medicine 73:233-240, 1994.
21. Bratusch-Marrain PR, Smith D, DeFronzo RA. The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab 55:973-982, 1982.
22. Rizza RA, Mandarino LJ, Gerich JE. Effects of growth hormone on insulin action in man: mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 31:663-669, 1982.
23. Moller N, Moller J, Jorgensen JO, Ovesen P, Schmitz O, Alberti KG, Christiansen JS. Impact of 2 weeks high dose growth hormone treatment on basal and insulin stimulated substrate metabolism in humans. Clin Endocrinol 5:575-581, 1993.
24. Bates RW, Scow RO, Lacy PE. Induction of permanent diabetes in rats by pituitary hormones from a transplantable mammotropic tumour: concomitant changes in organ weights and the effect of adrenalectomy. Endocrinology 78:826-836, 1966.
25. Davidson MB, Melmed S. Hepatocyte insulin binding and action in rats with sommatomammotrophic tumours. Diabetologia 25:60-65, 1983.
26. Ng SF, Storlien LH, Kraegen EW, Chapman GE, Lazarus L. Effect of biosynthetic human growth hormone on insulin action in individual tissues of the rat in vivo. Metabolism 39:264-268, 1990.
27. McGrane MM, Yun J, Moorman AFM, Lamers W, Hendrick GK, Arafah BM, Park EA, Wagner TE, Hanson RW. Metabolic effects of developmental, tissue- and cell-specific expression of a chimeric phosphoenolpyruvate carboxykinase (GTP)/bovine growth hormone gene in transgenic mice. J Biol Chem 65:22371-22379, 1990.
28. Valera A, Rodriguez-Gil JE, Yun JS, McGrane MM, Hanson RW, Bosch F. Glucose metabolism in transgenic mice containing a chimeric P-enolpyruvate carboxykinase/bovine growth hormone. FASEB J 7:791-800, 1993.
29. Costa C, Solanes G, Visa J, Bosch F. Transgenic rabbits overexpressing growth hormone develop acromegaly and diabetes mellitus. FASEB J 12:1455-1460, 1998.
30. Ikeda A, Chang K-T, Matsumoto Y, Furuhata Y, Nishishara M, Sasaki F, Takahashi M. Obesity and insulin resistance in human growth hormone transgenic rats. Endocrinology 139:3057-3063, 1998.
31. Schwartz J. Enhanced insulin sensitivity in rats treated with antibodies to rat growth hormone. Endocrinology 107:877-883, 1980.
32. Bougneres P-F, Artavia-Loria E, Ferre P, Chaussain J-L, Job L-C. Effect of hypopituitarism and growth hormone replacement therapy on the production and utilization of glucose in childhood. J Clin Endocrinol Metab 61:1152-1157, 1985.
33. Hopwood NJ, Forsman PJ, Kenny FM, Drash AL. Hypoglycemia in hypopituitary children. Am J Dis Child 129:918-929, 1975.
34. Muggeo M, Bar RS, Roth J, Kahn CR, Gorden P. The insulin resistance of acromegaly: evidence for two alterations in the insulin receptor on circulating monocytes. J Clin Endocrinol Metab 48:17-25, 1979.
35. Lesniak MA, Roth J. Regulation of receptor concentration by homologous hormone: effect of human growth hormone on its receptor in IM-9 lymphocytes. J Biol Chem 251:3720-3729, 1976.
36. Maloff BL, Levine JH, Lockwood DH. Direct effects of growth hormone on insulin action in rat adipose tissue maintained in vitro. Endocrinology 107:538-544, 1980.
37. Foster CM, Hale PM, Jing HW, Schwartz J. Effects of human growth hormone on insulin-stimulated glucose metabolism in 3T3-F442A adipocytes. Endocrinology 123:1082-1088, 1988.
38. Ng F, Henderson T, Bromley J, Bornstein J. Modulation of hepatic insulin receptors by a human growth hormone fragment (hGH 6-13). Mol Cell Endocrinol 30:63-71, 1983.
39. Lippe BM, Kaplan SA, Golden MP, Hendricks SA, Scott ML. Carbohydrate tolerance and insulin receptor binding in children with hypopituitarism: responses after acute and chronic human growth hormone administration. J Clin Endocrinol Metab 53:507-513, 1981.
40. Rosenfeld RG, Wilson DM, Dollar LA, Bennett A, Hintz RL. Both human pituitary growth hormone and recombinant DNA-derived human growth hormone cause insulin resistance at a postreceptor site. J Clin Endocrinol Metab 54:1033-1038, 1982.
41. Bak JF, Moller N, Schmitz O. Effects of growth hormone on fuel utilization and muscle glycogen synthase activity in normal humans. Am J Physiol 260:E736-E742, 1991.
42. Kahn CR, Goldfine ID, Neville DM, De Meyts P. Alterations in insulin binding induced by changes in vivo in the levels of glucocorticoids and growth hormone. Endocrinology 103:1054-1066, 1978.
43. Nagashima K, Susuki S, Uchida S, Kuroume T. Effects of human growth hormone on erythrocyte insulin binding in growth hormone deficient children. Horm Metab Res 16:402-405, 1984.
44. Venkatesan N, Davidson MB. Insulin resistance in rats harbouring growth hormone-secreting tumors: decreased receptor number but increased kinase activity in liver. Metabolism 44:75-84, 1995.
45. Balbis A, Dellacha JM, Calandra RS, Bartke A, Turyn D. Down regulation of masked and unmasked insulin receptors in the liver of transgenic mice expressing bovine growth hormone gene. Life Sci 51:771-778. 1992.
46. Balbis A, Bartke A, Turyn D. Overexpression of bovine growth hormone in transgenic mice is associated with changes in hepatic insulin receptors and in their kinase activity. Life Sci 59:1363-1371, 1996.
47. Dominici FP, Cifone D, Bartke A, Turyn D. Alterations in the early steps of the insulin signaling system in skeletal muscle of GH-transgenic mice. Am J Physiol 277:E447-E454, 1999.
48. Pav J, Hilgertova J, Marek J, Sramkova J. Insulin binding to erythrocyte receptors in acromegalic patients in relation to the activity of acromegaly and to concomitant diabetes mellitus. Exp Clin Endocrinol 88:76-80, 1986.
49. Bolinder J, Ostman J, Werner S, Arner P. Insulin action in human adipose tissue in acromegaly. J Clin Invest 77:1201-1206, 1986.
50. Magri KA, Adamo M, LeRoith D, Etherton TD. The inhibition of insulin action and glucose metabolism by porcine growth hormone in porcine adipocytes is not the result of any decrease in insulin binding or insulin receptor kinase activity. Biochem J 266:101-113, 1990.
51. Thirone ACP, Carvalho CRO, Brenelli SL, Velloso LA, Saad MJA. Effect of chronic growth hormone treatment on insulin signal transduction in rat tissues. Mol Cell Endocrinol 130:33-42, 1997.
52. Smith TR, Elmendorf RS, David TS, Turinsky J. Growth hormone-induced insulin resistance: role of the insulin receptor, IRS-1, GLUT-1 and GLUT-4. Am J Physiol 272:E1071-E1079, 1997.
53. Gavin JR III, Roth J, Neville Jr DM, De Meyts P, Buell DN. Insulindependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. Proc Natl Acad Sci U S A 71:84-88, 1974.
54. Dominici FP, Balbis A, Bartke A. Turyn D. Role of hyperinsulinemia on hepatic insulin receptor concentration and autophosphorylation in the presence of high growth hormone levels in transgenic mice overexpressing GH gene. J Endocrinol 159:15-25, 1998.
55. Eriksson H, Ridderstrale M, Tornqvist HTI. Tyrosine phosphorylation of the growth hormone (GH) receptor and Janus tyrosine kinase-2 is involved in the insulin-like actions of GH in primary rat adipocytes. Endocrinology 136:5093-5101, 1995.
56. Thirone ACP, Paez-Espinosa EV, Carvalho CRO, Saad MJA. Regulation of insulin-stimulated tyrosine phosphorylation of Shc and IRS-1 in the muscle of rats: effect of growth hormone and epinephrine. FEBS Lett 421:191-196, 1998.
57. Dominici FP, Cifone D, Bartke A, Turyn D. Loss of sensitivity to insulin at early events of the insulin signaling pathway in liver of growth hormone-transgenic mice. J Endocrinol 161:383-392, 1999.
58. Myers MG, Sun XJ, White MF. The IRS-1 signaling system. Trends Biochem Sci 19:289-293, 1994.
59. Carter-Su C, Schwartz J, Smith LS. Molecular mechanism of growth hormone action. Annu Rev Physiol 58:187-207, 1996.
60. Kopchick JJ, Andry JM. Growth hormone (GH), GH receptor, and signal transduction. Mol Genet Metab 71:293-314, 2000.
61. Waxman DJ, Frank SJ. Growth hormone action. Signaling via a JAK/STAT-coupled receptor. In: Conn PM, Means AR, Eds. Principles of Molecular Regulation. Totowa, New Jersey: Humana Press, Vol 4:pp55-83, 2000.
62. Kelly PA, Goujon L, Sotiropoulos A, Dinerstein H, Esposito N, Edery M, Finidori J, Postel-Vinay MC. The prolactin/growth hormone receptor family. Endocrine Rev 12:235-251, 1991.
63. Argetsinger LS, Campbell GS, Yang X, Witthunhn BA, Silvennoinen O, Ihle JN, Carter-Su C. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74:237-244, 1993.
64. Souza SC, Frick PG, Yip R, Lobo RB, Tai LR, Goodman HM. Growth hormone stimulates tyrosine phosphorylation of insulin receptor substrate-1. J Biol Chem 269:30085-30088, 1994.
65. Ridderstråle M, Degerman E, Tornqvist H. Growth hormone stimulates the tyrosine phosphorylation of the insulin receptor substrate-1 and its association with phosphatidylinositol 3-kinase in primary adipocytes. J Biol Chem 270:3471-3474, 1995.
66. Argetsinger LS, HSU GW, Myers MG Jr, Billestrup N, White MF, Carter-Su C. Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. J Biol Chem 270:14685-14692, 1995.
67. Argetsinger LS, Norsted G, Billestrup N, White MF, Carter-Su C. Growth hormone, interferon-γ, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling. J Biol Chem 271:29415-29421, 1996.
68. S6K pathways. Biochem J 315:517-522, 1996.
69. Yamauchi T, Kaburagi Y, Ueki K. Tsuji Y, Stark GR, Kerr IM, Tsushima T, Akanuma Y, Komuro I, Tobe K, Yazaki Y, Kadowaki T. Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2 and -3, their association with p85 phosphatidylinositol 3-kinase (PI3-kinase) and concomitantly PI3-kinase activation via JAK2 kinase. J Biol Chem 273:15719-15726, 1998.
70. Thirone ACP, Carvalho CRO, Saad MJA. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and SHC in rat tissues. Endocrinology 140:55-62, 1999.
71. Liang L, Jiang J, Frank SJ. Insulin receptor substrate-1-mediated enhancement of growth hormone-induced mitogen-activated protein kinase activation. Endocrinology 141:3328-3336, 2000.
72. Vanderkuur J, Allevato G, Billestrup N, Norsted G, Carter Su C. Growth hormone promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2. J Biol Chem 270:7587-7593, 1995.
73. Vanderkuur JA, Butch ER, Waters SB, Pessin JE, Guan KL, Carter-Su C. Signaling molecules involved in coupling growth hormone receptor to mitogen-activated protein kinase activation. Endocrinology 138:4301-4307, 1997.
74. Chow JC, Ling PR, Zhensheng Q, Laviola L, Ciccarone A, Bistrian BR, Smith R. Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo. Endocrinology 137:2880-2886, 1996.
75. Ridderstrale M, Tornqvist H. PI 3-kinase inhibitor wortmannin blocks the insulin-like effects of growth hormone in isolated rat adipocytes. Biochem Biophys Res Commun 203:306-310, 1994.
76. Piwien-Pilipuk G, Van Mater D, Ross SE, MacDougald OA, Schwartz J. Growth hormone regulates phosphorylation and function of CCAAT/enhancer-binding protein-β by modulating Akt and glycogen synthase kinase-3. J Biol Chem 276:19664-19671, 2001.
77. Yokota I, Hayashi H, Matsuda J, Saijo T, Naito E, Ito M, Ebina Y, Kuroda Y. Effect of growth hormone on the translocation of GLUT4 and its relation to insulin-like and anti-insulin action. Biochim Biophys Acta 1404:451-456, 1998.
78. Sakaue H, Ogawa, Takata M, Kuroda S, Kotani K, Matsumoto M, Sakaue M, Nishio S, Ueno H, Kasuga M. Phosphoinositide 3-kinase is required for insulin-induced but not for growth hormone- or hyperosmolarity-induced glucose uptake in 3T3-L1 adipocytes. Mol Endocrinol 11:1552-1562, 1997.
79. Cousin SP, Hugl SR, Myers MG Jr, White MF, Reifel-Miller A, Rhodes CJ. Stimulation of proliferation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling. Biochem J 344:649-658, 1999.
80. Baumann CA, Ribon V, Kanzaki M, Thurmond DC, Mora S, Shigematsu S, Bickel PE, Pessin JE, Saltiel AR. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 407:202-207, 2000.
81. Chiang SH, Baumann CA, Kanzaki M, Thurmond DC, Watson RT, Neudauer CL, Macara IG, Pessin JE, Saltiel AR. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 410:944-948, 2001.
82. Cas and CrkII. J Biol Chem 273:33864-33875, 1995.
83. Adams TE, Hansen JA, Starr R, Nicola NA, Hilton DJ, Billestrup N. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. J Biol Chem 273:1285-1287, 1998.
84. Mooney RA, Senn J, Cameron S, Inamdar N, Boivin LM, Shang Y, Furlanetto RW. Suppressors of cytokine signaling (SOCS)-1 and 6 associate with and inhibit the insulin receptor: a potential mechanism for cytokine mediated insulin resistance. J Biol Chem 276:25889-25893, 2001.
85. Takano A, Haruta T, Iwata M, Usui I, Uno T, Kawahara J, Ueno E, Sasaoka T, Kobayashi M. Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes. Diabetes 50:1891-1900, 2001.
86. Yakar S, Liu J-L, Fernandez AM, Wu Y, Schally AV, Frystyk J, Chernausek SD, Mejia W, LeRoith D. Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes 50:1110-1118, 2001.
87. Zhou Y, Xu BC, Maheswari HG, He L, Reed M, Lozykowski M, Okada S, Cataldo L, Coschigano K, Wagner TE, Baumann G, Kopchick JJ. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci U S A 94:13215-13220, 1997.
88. Schaible R, Gowen JW. A new dwarf mouse. Genetics 46:896, 1961.
89. Andersen B, Pearse RV, Jenne K, Sornson M, Lin SC, Bartke A, Rosenfeld MG. The Ames dwarf gene is required for Pit-1 gene activation. Dev Biol 172:495-503, 1995.
90. Bartke A. Genetic models in the study of anterior pituitary hormones. In: Shire JGM, Ed. Genetic Variation in Hormone Systems. Boca Raton, FL: CRC Press, pp 113-126, 1979.
91. Borg KE, Brown-Borg HM, Bartke A. Assessment of the primary adrenal cortical and pancreatic hormone basal levels in relation to plasma glucose and age in the unstressed Ames dwarf mouse. Proc Soc Exp Biol Med 210:126-133, 1995.
92. Hauck SJ, Hunter WS, Danilovich N, Kopchick JJ, Bartke A. Reduced levels of thyroid hormones, insulin, and glucose, and lower body core temperature in the growth hormone receptor/binding protein knockout mouse. Exp Biol Med 226:552-558, 2001.
93. Dominici FP, Arostegui Diaz G, Kopchick JJ, Bartke A, Turyn D, Compensatory alterations of insulin signal transduction in liver of growth hormone receptor knockout mice. J Endocrinol 166:579-590, 2000.
94. Coschigano KT, Riders ME, Bellush LL, Kopchick JJ. Glucose metabolism in growth hormone receptor/binding protein gene disrupted mice. 81st Annual Meeting of the Endocrine Society, San Diego, CA, Abstract P3-537, pp553, 1999.
95. Anai M, Funaki M, Ogihara T, Kanda A, Onishi Y, Sakoda H, Inukai K, Nawano M, Fukushima Y, Yazaki Y, Kikuchi M, Oka Y, Asano T. Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high fat-fed rats. Diabetes 48:158-169, 1999.
96. Ogihara T, Asano T, Ando K, Chiba Y, Sekine N, Sakoda H, Anai M, Onishi Y, Fujishiro M, Ono H, Shojima N, Inukai K, Fukushima Y, Kikuchi M, Fujita T. Insulin resistance with enhanced insulin signaling in high-salt diet-fed rats. Diabetes 50:573-583, 2001.
97. Kristal BS, Yu BP. An emerging hyphothesis synergistic induction of aging by free radicals and Maillard reactions J Gerontol 47:107-114, 1992.
98. Facchini FS, Hua NW, Reaven GM, Stoohs RA. Hyperinsulinemia: the missing link among oxidative stress and age-related diseases? Free Radic Biol Med 29:1302-1306, 2000.
99. Parr T. Insulin exposure controls the rate of mammalian aging. Mech Ageing Dev 88:75-82, 1996.
100. Kimura KD, Tissenbaum HA, Liu Y, Ruvkun G. daf-2, and insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277:942-946, 1997.
101. Murakami S, Tedesco PM, Cypser JR, Johnson TE. Molecular genetic mechanisms of life span manipulation in Caenorhabditis elegans. Ann N Y Acad Sci 908:40-49, 2000.
102. Clancy DJ, Gems D, Harshman LG, Oldham S, Stocker H, Hafen E, Leevers SJ, Partridge L. Extension of life span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292:104-106, 2001.
103. Tatar M, Kopelman A, Epstein D, Tu MP, Yin CM, Garofalo RS. A mutant Drosophila insulin receptor homolog that extends life and impairs neuroendocrine function. Science 292:107-110, 2001.
104. Wolf E, Kahn E, Ehrlein J, Hermanns W, Brem G, Wanke R. Effects of long-term elevated serum levels of growth hormone on life expectancy: lessons from transgenic animal models. Mech Ageing Dev 68:71-87, 1993.
105. Steger RW, A Bartke, Cecim JM. Premature ageing in transgenic mice expressing different growth hormone genes. J Reprod Fertil 46(Suppl):61-75, 1993.
106. Brown-Borg H, K Borg, C Meliska, Bartke A. Dwarf mice and the aging process Nature 384:33, 1996.
107. Coschigano KT, Clemmons D, Bellush LL, Kopchick JJ. Assessment of growth parameters and life span of GHR/GHBP gene-disrupted mice. Endocrinology 141:2608-2613, 2000.
108. Flurkey K, Papaconstantinou J, Miller RA, Harrison DE. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci U S A 98:6736-6741, 2001.
109. Fouchereau-Peron M, Broer Y, Rosselin G. Growth hormone and insulin binding to isolated hepatocytes in the genetically dwarf mouse. Biochim Biophys Acta 631:451-462, 1980.
110. Bartke A, Brown-Borg HM, Bode AM, Carlson J, Hunter WS, Bronson RT. Does growth hormone prevent or accelerate aging? Exp Gerontol 33:675-687, 1998.
111. Dominici FP, Hauck S, Argentino DP, Bartke A, Turyn D. Increased insulin sensitivity and up-regulation of insulin receptor, insulin receptor substrate (IRS)-1 and IRS-2 in liver of Ames dwarf mice. J Endocrinol (in press).